Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Meyer

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Journal of Pharmaceutical Sciences|September 1, 1978
Relative bioavailability of meprobamate tablets in humansM C Meyer, A P Melikian, A B Straughn
The Journal of Maternal-Fetal Medicine|March 1, 1997
Labor induction with a prenatal diagnosis of fetal macrosomiaW L Leaphart, M C Meyer, E L Capeless
Journal of Pharmaceutical Sciences|September 1, 1991
Circadian rhythms in theophylline disposition: simulations and observations in the dogR J Rackley, M C Meyer, A B Straughn
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1980
Bioavailability of microsize and ultramicrosize griseofulvin products in manA B Straughn, M C Meyer, G Raghow, et al.
Journal of Clinical Pharmacology|February 1, 1982
Serious bioavailability problems with a generic prolonged-release quinidine gluconate productM C Meyer, A B Straughn, P Lieberman, et al.
Pharmaceutical Development and Technology|August 1, 1997
Relating formulation variables to in vitro dissolution using an artificial neural networkN K Ebube, T McCall, Y Chen, et al.
Biophysical Journal|April 9, 2008
Influence of lipid saturation grade and headgroup charge: a refined lung surfactant adsorption modelU Klenz, M Saleem, M C Meyer, et al.
Biopharmaceutics & Drug Disposition|January 1, 1982
HPLC determination of benzthiazide in biologic materialM C Meyer, P Hwang, A B Straughn, et al.
Obstetrics and Gynecology|August 12, 1998
Intolerance to volume expansion: a theorized mechanism for the development of preeclampsiaI M Bernstein, M C Meyer, G Osol, et al.
Current Pharmaceutical Design|April 28, 2005
Phospholipase A2 inhibitors as potential anti-inflammatory agentsM C Meyer, P Rastogi, C S Beckett, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Journal of Pharmaceutical Sciences|September 1, 1978
Relative bioavailability of meprobamate tablets in humansM C Meyer, A P Melikian, A B Straughn
The Journal of Maternal-Fetal Medicine|March 1, 1997
Labor induction with a prenatal diagnosis of fetal macrosomiaW L Leaphart, M C Meyer, E L Capeless
Journal of Pharmaceutical Sciences|September 1, 1991
Circadian rhythms in theophylline disposition: simulations and observations in the dogR J Rackley, M C Meyer, A B Straughn
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1980
Bioavailability of microsize and ultramicrosize griseofulvin products in manA B Straughn, M C Meyer, G Raghow, et al.
Journal of Clinical Pharmacology|February 1, 1982
Serious bioavailability problems with a generic prolonged-release quinidine gluconate productM C Meyer, A B Straughn, P Lieberman, et al.
Pharmaceutical Development and Technology|August 1, 1997
Relating formulation variables to in vitro dissolution using an artificial neural networkN K Ebube, T McCall, Y Chen, et al.
Biophysical Journal|April 9, 2008
Influence of lipid saturation grade and headgroup charge: a refined lung surfactant adsorption modelU Klenz, M Saleem, M C Meyer, et al.
Biopharmaceutics & Drug Disposition|January 1, 1982
HPLC determination of benzthiazide in biologic materialM C Meyer, P Hwang, A B Straughn, et al.
Obstetrics and Gynecology|August 12, 1998
Intolerance to volume expansion: a theorized mechanism for the development of preeclampsiaI M Bernstein, M C Meyer, G Osol, et al.
Current Pharmaceutical Design|April 28, 2005
Phospholipase A2 inhibitors as potential anti-inflammatory agentsM C Meyer, P Rastogi, C S Beckett, et al.
Pageof 12